Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: I think

I think

posted on Feb 15, 2007 09:24AM

it is more important that management "make money" with the monies coming in. And if they can't...it's time to bring in someone who can. It should aid SP far more than a temp. rise due to divi and better than spending a bunch of money for share buyback. If NEC were $25mil., would buying back 50mil. shares really bring in large numbers of new investors willing to buy the share price up? Not high enough to spend that kind of money imo.

Still hoping for a courtromm holdout being this close to Markman and trial, but nice job by TPL to get NEC. Did seem to state in PR that that sector was more expensive so I too am looking for better than Fugitsu numbers. Now time for PTSC management to prove worthiness imo. joe

Share
New Message
Please login to post a reply